A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Top Cited Papers
- 10 March 2020
- journal article
- review article
- Published by Elsevier in Journal of Critical Care
- Vol. 57, 279-283
- https://doi.org/10.1016/j.jcrc.2020.03.005
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studiesBioScience Trends, 2020
- [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].2020
- Chloroquine for the 2019 novel coronavirus SARS-CoV-2International Journal of Antimicrobial Agents, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Ethical and legal framework and regulation for off-label use: European perspectiveTherapeutics and Clinical Risk Management, 2014
- Effects of chloroquine on viral infections: an old drug against today's diseasesThe Lancet Infectious Diseases, 2003